Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

4.68
-0.1700-3.51%
Volume:427.83K
Turnover:1.97M
Market Cap:176.61M
PE:-4.50
High:4.86
Open:4.77
Low:4.43
Close:4.85
52wk High:7.19
52wk Low:1.00
Shares:37.74M
Float Shares:22.29M
Volume Ratio:1.10
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0401
EPS(LYR):-1.1641
ROE:-50.12%
ROA:-30.80%
PB:2.33
PE(LYR):-4.02

Loading ...

Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 28, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities